Trial intelligence / Profile preview

Comparison of steroid injection, night splinting, and combination therapy for adult trigger digits

TCTR20210429001Phase 4Not yet recruiting

Sponsor
The Faculty of Medicine Endowment Fund
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylprednisolone + lidocaine in trigger finger, sponsored by The Faculty of Medicine Endowment Fund. Planned start May 2021; status: not yet recruiting.

02

Drugs

methylprednisolone + lidocaine
03

Conditions

trigger finger

Beyond the preview

Go deeper on TCTR20210429001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210429001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call